Aequitas 2024 Asia IPO Pipeline - India
In this note, we will take a look at the Asia Pacific IPO pipeline for 2024, following up with India after having looked at Hong Kong earlier.
660 Views
Concord Biotech IPO Trading - Strong Subscription Rates, Peers Have Moved up Since Last Note
Concord Biotech Ltd (658823Z IN) raised US$188m in its India IPO. In this note, we will talk about the trading dynamics.
518 Views
Concord Biotech IPO - Peer Comparison & Valuation - Smaller in Scale but Wider in Margins
Concord Biotech Ltd (658823Z IN) is looking to raise around US$188m in its India IPO. In this note, we will undertake a peer comparison, and share...
962 Views
Concord Biotech IPO - RHP Updates - Continued Growing Although Concentration Risk Remains Elevated
Concord Biotech Ltd (658823Z IN) is looking to raise around US$188m in its India IPO. Concord is an India-based biopharma firm, which develops and...
516 Views
Concord Biotech Pre-IPO - Sales Have Been Growing but Watch Out for Its High Concentration Risk
Concord Biotech Ltd (658823Z IN) is looking to raise around US$250m in its upcoming India IPO. Concord is an India-based biopharma firm, which...
526 Views